Global Digital Biomarker Market TOC
- An Outline of the Global Digital Biomarker Market
- Market Definition
- Market Segmentation
- Industry Overview
- Assumptions & Abbreviations
- Research Methodology & Approach
- Research Process
- Primary Research
- Manufacturers
- Service Providers
- End Users
- Secondary Research
- Market Size Estimation
- Summary of the Report for Key Decision Makers
- Forces of Market Constituents
- Factors/drivers impacting the growth of the market
- Market trends for better business practices
- Key Market Opportunities for Business Growth
- Major Roadblocks for the Market Growth
- Decarbonization Strategy and Carbon Credit Benefits for Market Players
- Global Government Decarbonization Plans/Goals by Each Country under 2015 Agreement Agreed by 200 Countries
- Measures taken by Countries to Reduce Carbon Footprints
- Carbon Credits and Subsidy Plans/Benefits Rolled out by the Government for Market Players
- Effective Ways to Harness Carbon-Credits and Impact on Profit Margins
- Demand Impact on the Companies Opting for Carbon Credits
- Government Regulation: How They Would aid Business?
- Industry Risk Analysis
- Global Economic Outlook: Challenges for Global Recovery and its Impact on Global Digital Biomarker Market
- Ukraine-Russia crisis
- Potential US economic slowdown
- Pipeline Analysis
- Industry Growth Outlook
- Industry Value Chain Analysis
- End User Analysis
- Competitive Positioning: Strategies to Differentiate a Company From its Competitor
- Competitive Model: A Detailed Inside View for Investors
- Company Market Share (2023)
- Business Profile of Key Enterprise
- nQ Medical
- ALTOIDA
- ActiGraph, LLC
- VivoSense
- EVOCAL Health GmbH
- Koneksa
- Cosinuss GmbH
- Biofourmis
- Lunit Inc.
- IMVARIA Inc.
- Global Digital Biomarker Market Outlook
- Market Overview
- Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
- Year-on-Year (YoY) Growth Trend Analysis
- Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Data Collection Tools, Market Value (USD Million) and CAGR, 2023-2036F
- Mobile Apps, Market Value (USD Million) and CAGR, 2023-2036F
- Wearables, Market Value (USD Million) and CAGR, 2023-2036F
- Biosensors, Market Value (USD Million) and CAGR, 2023-2036F
- Contact-free sensors, Market Value (USD Million) and CAGR, 2023-2036F
- Others, Market Value (USD Million) and CAGR, 2023-2036F
- Data Integration Systems, Market Value (USD Million) and CAGR, 2023-2036F
- Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
- Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2023-2036F
- Parkinson’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
- Multiple Sclerosis, Market Value (USD Million) and CAGR, 2023-2036F
- Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
- Others, Market Value (USD Million) and CAGR, 2023-2036F
- Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Chronic Pain, Market Value (USD Million) and CAGR, 2023-2036F
- Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Diabetes, Market Value (USD Million) and CAGR, 2023-2036F
- Respiratory Conditions, Market Value (USD Million) and CAGR, 2023-2036F
- Other Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
- Wellness, Market Value (USD Million) and CAGR, 2023-2036F
- Disease Diagnosis, Market Value (USD Million) and CAGR, 2023-2036F
- Personalized Medication, Market Value (USD Million) and CAGR, 2023-2036F
- Drug Discovery and Development, Market Value (USD Million) and CAGR, 2023-2036F
- Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
- Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2023-2036F
- Healthcare Providers, Market Value (USD Million) and CAGR, 2023-2036F
- Others, Market Value (USD Million) and CAGR, 2023-2036F
- Global Digital Biomarker Market Segmentation Analysis (2023-2036) By Geography
- North America, Market Value (USD Million) and CAGR, 2023-2036F
- Europe, Market Value (USD Million) and CAGR, 2023-2036F
- Asia Pacific, Market Value (USD Million) and CAGR, 2023-2036F
- Latin America, Market Value (USD Million) and CAGR, 2023-2036F
- Middle East & Africa, Market Value (USD Million) and CAGR, 2023-2036F
- Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Cross Analysis of Components w.r.t. Application (USD Million), 2023
- North America Digital Biomarker Market Outlook
- Market Overview
- Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
- Year-on-Year (YoY) Growth Trend Analysis
- North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Data Collection Tools, Market Value (USD Million) and CAGR, 2023-2036F
- Mobile Apps, Market Value (USD Million) and CAGR, 2023-2036F
- Wearables, Market Value (USD Million) and CAGR, 2023-2036F
- Biosensors, Market Value (USD Million) and CAGR, 2023-2036F
- Contact-free sensors, Market Value (USD Million) and CAGR, 2023-2036F
- Others, Market Value (USD Million) and CAGR, 2023-2036F
- Data Integration Systems, Market Value (USD Million) and CAGR, 2023-2036F
- North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
- Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2023-2036F
- Parkinson’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
- Multiple Sclerosis, Market Value (USD Million) and CAGR, 2023-2036F
- Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
- Others, Market Value (USD Million) and CAGR, 2023-2036F
- Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Chronic Pain, Market Value (USD Million) and CAGR, 2023-2036F
- Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- Diabetes, Market Value (USD Million) and CAGR, 2023-2036F
- Respiratory Conditions, Market Value (USD Million) and CAGR, 2023-2036F
- Other Diseases, Market Value (USD Million) and CAGR, 2023-2036F
- North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
- Wellness, Market Value (USD Million) and CAGR, 2023-2036F
- Disease Diagnosis, Market Value (USD Million) and CAGR, 2023-2036F
- Personalized Medication, Market Value (USD Million) and CAGR, 2023-2036F
- Drug Discovery and Development, Market Value (USD Million) and CAGR, 2023-2036F
- North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
- Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2023-2036F
- Healthcare Providers, Market Value (USD Million) and CAGR, 2023-2036F
- Others, Market Value (USD Million) and CAGR, 2023-2036F
- North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- North America Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
- US, Market Value (USD Million) and CAGR, 2023-2036F
- Canada, Market Value (USD Million) and CAGR, 2023-2036F
- Europe Digital Biomarker Market Outlook
- Market Overview
- Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
- Year-on-Year (YoY) Growth Trend Analysis
- Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
- Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
- Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
- Europe Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
- UK, Market Value (USD Million) and CAGR, 2023-2036F
- Germany, Market Value (USD Million) and CAGR, 2023-2036F
- France, Market Value (USD Million) and CAGR, 2023-2036F
- Italy, Market Value (USD Million) and CAGR, 2023-2036F
- Spain, Market Value (USD Million) and CAGR, 2023-2036F
- Russia, Market Value (USD Million) and CAGR, 2023-2036F
- Netherlands, Market Value (USD Million) and CAGR, 2023-2036F
- Rest of Europe, Market Value (USD Million) and CAGR, 2023-2036F
- Asia Pacific Digital Biomarker Market Outlook
- Market Overview
- Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
- Year-on-Year (YoY) Growth Trend Analysis
- Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
- Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
- Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
- Asia Pacific Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
- China, Market Value (USD Million) and CAGR, 2023-2036F
- Japan, Market Value (USD Million) and CAGR, 2023-2036F
- India, Market Value (USD Million) and CAGR, 2023-2036F
- Australia, Market Value (USD Million) and CAGR, 2023-2036F
- South Korea, Market Value (USD Million) and CAGR, 2023-2036F
- Singapore, Market Value (USD Million) and CAGR, 2023-2036F
- Rest of Asia Pacific, Market Value (USD Million) and CAGR, 2023-2036F
- Latin America Digital Biomarker Market Outlook
- Market Overview
- Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
- Year-on-Year (YoY) Growth Trend Analysis
- Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
- Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
- Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
- Latin America Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
- Mexico, Market Value (USD Million) and CAGR, 2023-2036F
- Argentina, Market Value (USD Million) and CAGR, 2023-2036F
- Brazil, Market Value (USD Million) and CAGR, 2023-2036F
- Rest of Latin America, Market Value (USD Million) and CAGR, 2023-2036F
- Middle East & Africa Digital Biomarker Market Outlook
- Market Overview
- Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
- Year-on-Year (YoY) Growth Trend Analysis
- Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
- Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
- Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
- Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
- Middle East & Africa Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
- GCC, Market Value (USD Million) and CAGR, 2023-2036F
- Israel, Market Value (USD Million) and CAGR, 2023-2036F
- South Africa, Market Value (USD Million) and CAGR, 2023-2036F
- Rest of Middle East & Africa, Market Value (USD Million) and CAGR, 2023-2036F
Digital Biomarkers Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Digital Biomarkers Market in 2025 is assessed at USD 4.77 billion. The global market size surpassed USD 3.79 billion in 2024 and is projected to witness a CAGR of over 32.2%, crossing USD 142.77 billion revenue by 2037. North America is estimated to accumulate USD 64.25 billion by 2037, driven by a sharp rise in Alzheimer’s cases.
The market growth is driven by growing prevalence of chronic diseases. Because most chronic diseases have a slow beginning, there is a possibility to create prognostic digital biomarkers that are recognized early enough to match the current measurement standards as normal levels. This will help in developing targeted therapies and control the burden of chronic illness.
In addition, advancement in digital health technology will fuel the market revenue. The use of digital biomarkers in decentralized clinical trials has had a considerable impact on remote patient monitoring. Digital health technologies have the potential to fundamentally change the way clinical trials are executed. Merck launched the digitally enabled clinical trial project in 2021, according to the National Centre for Biotechnology Information, to promote the use of digital technologies in clinical trials.
Digital Biomarker Sector: Growth Drivers and Challenges
Growth Drivers
- Remote Sensing Technologies are Getting More Popular – These technological devices also enable professionals to find patients and retrieve their medical records more rapidly. Remote sensing and monitoring technologies allow healthcare providers to obtain timely information about a patient's vital signs without needing to schedule an in-person visit.
- Growing Use of Biomarkers for Identifying Neurological Disorder– The number of deaths from neurological illnesses has grown by 39% since 1990. The growing environmental and life pressure has increased the frequency of neurological disorders, such as Alzheimer's disease, dementia, and others. Moreover, healthcare providers and the government are taking initiative to address the problem. Alzheimer's Disease Biomarkers Summit is a digital forum dedicated to addressing the issue of establishing clinically proven markers for early identification and Alzheimer's treatment.
- Rising Development of Drug Delivery Method– AstraZeneca is working to develop new modalities for drug delivery systems to target and control the release of molecules directly into the tissues and cells. Biomarkers enable to increase in the extent of the new drug to reach the desired target.
Challenges
- Standards for Interoperability of Digital Biomarkers are Lacking- Healthcare systems in nations with a low income face intrinsic limitations in addressing seamless connectivity, offering substantial obstacles for healthcare interoperability. Furthermore, the majority of healthcare systems in those locations lack the necessary data insights as well as integration technologies, which is expected to impede product adoption.
- • Biomarker-related security risks
- Long-duration timeline for the development of biomarkers
Digital Biomarkers Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
32.2% |
|
Base Year Market Size (2024) |
USD 3.79 billion |
|
Forecast Year Market Size (2037) |
USD 142.77 billion |
|
Regional Scope |
|
Digital Biomarker Segmentation
Therapeutic Area (Cardiovascular Diseases, Neurodegenerative Disorders, Sleep & Movement Diseases, Chronic Pain, Gastrointestinal Diseases, Diabetes, Respiratory Conditions)
The neurogenerative disorder segment in the digital biomarkers market is expected to account for a significant revenue share by 2037. The segment growth can be attributed to rising cases of neurogenerative disorder. Owing to the low success rate of treatment and drugs, these diseases are continuously increasing and are becoming hard to tackle. In 2020, there were approximately 55 million people living with dementia worldwide. This figure is expected to nearly double every 20 years, hitting 78 million in 2030 and around 139 million in 2050.
Application (Wellness, Disease Diagnosis, Personalized Medication, Drug Discovery & Development)
The drug discovery & development segment is expected to hold largest digital biomarkers market share by 2037. The segment growth is due to growing discovery of new drugs and the rise in the number of clinical trials being carried out for novel drugs. As life sciences businesses expand to put money into and advance new treatments and vaccines across a wide range of disease areas, the total number of items currently being developed in human trials globally surpasses 6,000, a rise of 68% over the 2016 level.
Our in-depth analysis of the global market includes the following segments:
|
Component |
|
|
Therapeutic Area |
|
|
Application |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Digital Biomarker Industry- Regional Synopsis
North American Market Forecast
The North America digital biomarkers market share is poised to surpass 45% by 2037. The market growth is propelled by surging cases of Alzheimer's disease in the region. North America accounts for the vast majority of instances worldwide. Alzheimer's is one of the top ten leading causes of death and disability in the United States, according to the Centers for Disease Control and Prevention. According to The Fisher Centre for Alzheimer's Research Foundation, someone in the United States develops Alzheimer's disease every 65 seconds. Over 6 million people in the United States were living with Alzheimer's Disease in 2021.
Europe Market Statistics
The European digital biomarkers market is estimated to observe high growth till 2037. The market is expanding rapidly as a result of increased government assistance in major European countries such as Germany, the United Kingdom, Spain, and Russia. Increased government initiatives promoting mHealth are also expected to open up new opportunities for regional manufacturers. Moreover, the government is also working to propel the adoption of digital health in the region. The government established the European Health Data Space (EHDS) in 2022, allowing people across Europe to control and use their health data in their own nation.
Companies Dominating the Digital Biomarker Landscape
- IMVARIA Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- nQ Medical
- ALTOIDA
- ActiGraph, LLC.
- VivoSense
- EVOCAL Health GmbH
- Koneksa Health
- Cosinuss GmbH
- Biofourmis
- Lunit Inc.
Recent Developments
- June 2023: Koneska Health joined forces with Beacon Biosignals, a biomarker platform engineered in the United States that is designed to speed up clinical trials and facilitate novel medications for patients with neurological and psychiatric diseases, to conduct clinical trials
- April 2023: ActiGraph announces the collaboration with Precision Digital Health (PDH), a U.S.-based company that provides wearable and biomarker data.
Author Credits: Radhika Pawar
- Report ID: 3217
- Published Date: Apr 23, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Digital Biomarkers Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
See our insights in action - schedule your demo now!
